Immune Intelligence Unlocked.
Our AI deciphers the immune system for improved patient outcomes.
Drug Discovery & De-Risking
Highly individual immune responses limit our ability to harness the adaptive immune system. By deciphering single patient responses into generalizable patterns, we identify new targets, develop better vaccines, identify therapeutic antibodies, and discover novel biomarkers.
Response Prediction
Leverage the intelligence of the immune system to predict which patients will respond to which therapies in cancer and autoimmune diseases. Optimize your clinical trials and patient access to your 2L/3L treatments.
Biomarker Development
Translate immune repertoire data into powerful biomarkers for diagnostics and clinical endpoints. Our AI decodes the complexity of the immune system to build highly predictive CDx for oncology, infectious, and autoimmune diseases.
Tailored Solutions
Accelerating discovery and development for every stage of the pipeline.
For Biotech
Unlock novel targets directly from human immunology. MyImmune's AI maps epitope-specific antibody clusters with >95% purity.
Learn More →
For Pharma
De-risk clinical trials with AI Patient Stratification. Decode adaptive immune responses to predict immunotherapy outcomes.
Learn More →
For CROs
Translate immune repertoire data into powerful biomarkers. Build highly predictive CDx for oncology and infectious diseases.
Learn More →Scientific Capabilities
Disease Detection
MyImmune leverages paratope networks to accurately detect diseases and identify therapeutic cells for precision medicine.
Read Paper →Antibody Clustering
By clustering CDR sequences, MyImmune identifies antigen-specific antibodies to speed up therapeutic development.
Read Paper →Led by pioneers in Computational Immunology and AI.
Our team combines world-class scientific expertise with business acumen to build trust and deliver results.
Ready to decode the immune system?
Get in touch to leverage the full potential of the adaptive immune repertoire